2024 CURE Rare Epilepsy Partnership Award

The purpose of this funding opportunity is to stimulate and accelerate discovery on rare epilepsies through the development of necessary research tools, techniques, model systems, and data collection platforms.

2024 partners include: 

• ASXL Rare Research
• Family With Sequence Similarity 177 Member A1 (FAM177A1) disorder
• Heterogenous Nuclear Ribonucleoproteins (HNRNPs) disorder
• Kleefstra Syndrome
• KCNT1-related epilepsy

Funding: $100,000
Duration: 1 year

Research authority due date: 2.6.24

LOI (required) due date: 11.6.24
Full proposal due date: 28.8.24